JPS6366200B2 - - Google Patents
Info
- Publication number
- JPS6366200B2 JPS6366200B2 JP17806181A JP17806181A JPS6366200B2 JP S6366200 B2 JPS6366200 B2 JP S6366200B2 JP 17806181 A JP17806181 A JP 17806181A JP 17806181 A JP17806181 A JP 17806181A JP S6366200 B2 JPS6366200 B2 JP S6366200B2
- Authority
- JP
- Japan
- Prior art keywords
- acid
- culture
- valine
- medium
- esters
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 13
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 241000894006 Bacteria Species 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 8
- FGKJLKRYENPLQH-UHFFFAOYSA-N isocaproic acid Chemical compound CC(C)CCC(O)=O FGKJLKRYENPLQH-UHFFFAOYSA-N 0.000 claims description 8
- QHKABHOOEWYVLI-UHFFFAOYSA-N 3-methyl-2-oxobutanoic acid Chemical compound CC(C)C(=O)C(O)=O QHKABHOOEWYVLI-UHFFFAOYSA-N 0.000 claims description 6
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 6
- 241000187747 Streptomyces Species 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 4
- 239000004474 valine Substances 0.000 claims description 4
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 claims description 3
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 claims description 3
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 3
- 230000003115 biocidal effect Effects 0.000 claims 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 23
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 235000002639 sodium chloride Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 229960004295 valine Drugs 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 240000008042 Zea mays Species 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- KZSNJWFQEVHDMF-AZXPZELESA-N dl-valine-2-13c Chemical compound CC(C)[13CH](N)C(O)=O KZSNJWFQEVHDMF-AZXPZELESA-N 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000010446 mirabilite Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 229940124339 anthelmintic agent Drugs 0.000 description 1
- 239000000921 anthelmintic agent Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 244000000013 helminth Species 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Description
本発明は駆虫剤及び殺ダニ剤として有用な抗生
物質B−41D、E及びGを工業的に有利に製造す
る方法に関する。
B−41D、E及びGは、ストレプトマイセス属
に属するB−41生産菌、例えばB−41−146株の
培養によつて得られる抗生物質であつて、次の構
造式を有し、
動物に寄生する蠕虫とくに線虫及び動植物に寄
生するダニの駆除等に有効であることは、特開昭
56−32481号公報、特願昭55−153141号(特開昭
57−77686号)明細書及び特願昭56−7091号(特
開昭57−120589号)明細書に知られている。
ところで、通常の方法でB−41生産菌を培養し
た場合、上記構造式に対応して25位がメチル基で
あるB−41A1、A3、B2及び25位がエチル基であ
るB−41A4、B3、B2などを同時に生産するため、
25位がイソプロピル基である最も活性なB−
41D、E及びGをより収率よく生産する方法が望
まれる。
本発明者等は、B−41生産菌を培養するに際
し、培地に特定の物質を添加することにより、B
−41D、E及びGが高収量で生産されることを見
い出した。
本発明は、ストレプトミセス属に属するB−41
生産菌を培養してB−41D、E及びGを製造する
に際し、バリン、イソ酪酸、イソ吉草酸、2−ケ
トイソ吉草酸、イソカプロン酸、これらの酸の塩
またはエステル、イソブタノール及びそのエステ
ルから選ばれた1種または2種以上を培地に添加
することを特徴とするB−41D、E及びGの製造
法である。
B−41生産菌、例えばストレプトミセス属B−
41−146株は通産省工業技術院微生物工業技術研
究所に微工研条寄第1072号として寄託されてお
り、その菌学的性状は特開昭50−29472号公報に
詳しく記載されている。本発明において使用する
菌には、上記B−41−146株を例えばX線照射、
紫外線照射、放射線照射、人工変異剤を用いて人
工変更したものであつて、B−41D、E及びGの
生産能を有するものは包含される。
本発明の方法において培地中に添加するバリン
はL体又はDLの光学異性体が用いられる。バリ
ン、イソ酪酸、イソ吉草酸、2−ケトイソ吉草
酸、イソカプロン酸のうちではL−またはDLバ
リン、イソ酪酸、2−ケトイソ吉草酸は好適に用
いられる。これらの酸の塩としてはナトリウム
塩、カリウム塩などがあげられ、エステルとして
はメチル、エチル、n−ブチルのような低級アル
キルエステルまたはベンジルエステルがあげられ
る。イソブタノール及びそのエステルも用いるこ
とができ、エステルとしては酢酸、プロピオン酸
のような低級飽和脂肪酸とのエステルがあげられ
る。上記添加物の 13C−ラベル化合物を用いた実
験では生成物の25位にイソプロピル基が特異的に
取り込まれていることが確認された。
培地に対するこれら添加物の添加量は一般的に
は0.001〜1W/V%、好ましくは0.005〜0.01W/
V%が添加される。添加時期は培地の調製時また
は培養中の適宜の段階で添加してもよい。
B−41生産菌の培養に用いられる培地は該微生
物が利用しうる栄養源を含むものならよく、上記
添加物を添加するほか、炭素源としてはグルコー
ス、しよ糖、殿粉、グリセリン、水あめ、糖蜜、
大豆油などが使用され、窒素源としてはスキムミ
ルク、大豆粉、小麦胚芽、肉エキス、ペプトン、
酵母菌体、コーンスチープ・リカー、硫酸アンモ
ニウム、硝酸アンモニウム等が使用される。この
ほか必要に応じて炭酸カルシウム、食塩、塩化カ
リ、リン酸塩類を添加することができる。
培養法としては、一般の抗生物質を生産する方
法と同じく液体培養法、とくに深部培養法が最も
適している。培養は好気的条件下で行なわれ、培
養に適当な温度は22〜30℃であるが多くの場合28
℃付近で培養する。培地の液性は概ねPH5.5〜8.0
の間でよく、望ましくはPH約6.5〜7.5の中性近傍
でよりよい結果をうることができる。培養はB−
41D、EおよびGの蓄積濃度が最大となる迄行な
うが、これに要する時間は、培養の方法、温度、
培地の組成など条件によつて差はあるものの、通
常約5〜15日程度である。
B−41各成分の検定にあたつては次の方法が用
いられる。すなわち、培養物3mlを小試験管にと
り、アセトン7mlを添加振とうして抽出し遠心分
離する。ここで得られた上澄の10〜20μをTLC
用板(メルク社製、Kieselgel 60 F254)上の所
定の位置に吸着せしめ、これをジオキサン:四塩
化炭素(18:82)で4時間展開後、二波長クロマ
トスキヤナを用いて245nmの波長(ブランクは
380nm)で測定し、その吸収量を標準物質のそ
れと比較し、算出する。
B−41D、EおよびGを培養物から採取するに
あたつては、活性炭、アルミナ、シリカゲルなど
の吸着剤、ダイヤイオンHP−10、HP−20(三菱
化成社製)などの合成吸着剤、アビセル(旭化成
社製)、紙などの固定剤、イオン交換樹脂、イ
オン交換ゲル過剤などが使用されうるが、以下
に示す採取方法が最も効果的である。
培養物を、けいそう土などの過助剤を用いて
別し、ここで得られたケーキをメタノール抽出
することにより、目的物はメタノール水に溶解し
てくる。これに水を加えた後、n−ヘキサンで抽
出し、これを減圧下で濃縮することにより、目的
物を含有するオイル状物質が得られる。これをシ
リカゲル(ワコーゲルC−200)のカラムに吸着
せしめ、n−ヘキサン:アセトン(95:5)で溶
出し、B−41Dを含有するフラクシヨン、B−
41Eを含有するフラクシヨンおよびB−41Gを含
有するフラクシヨンを集める。各フラクシヨンは
減圧下で濃縮し、ここで得られた残渣を少量のn
−ヘキサン:酢酸エチル(20:1)に溶解し、室
温に放置するとB−41D、B−41E、B−41Gが
それぞれ結晶状に得られる。
本発明の方法によれば特にB−41D、Eおよび
G成分の生成比率が非常に高く、また生成量も増
大するので、分離精製が容易になり工業生産上き
わめて有利な方法である。
以下実施例を挙げて、本発明を具体的に説明す
る。
実施例 1
種培地(シユクロース1%、ポリペプトン0.35
%、K2HPO40.05%)100mlを500mlエルレンマイ
ヤーフラスコに分注し、滅菌後、B−41−146株
を1白金耳接種し、48時間28℃で培養し、種培養
とした。
この1mlを主培地(グルコース4%、大豆粉1
%、スキムミルク1%、NaCl0.3%、コーンスチ
ープ・リカー0.2%及びCaCO30.05%)20ml含む
100mlエルレンマイヤーフラスコに接種し、28℃
で3日振とう培養したのち、DL−バリン−2−
13Cを0.01W/V%になるように添加し、さらに
2日間培養した。培養終了時、培養物中に生成し
たB−41群抗生物質のうちB−41Dの占める割合
は約65%、Eの割合は18%及びGの割合は5%で
あつた。なお添加物なしに培養したときD、Eお
よびGの占める割合は、それぞれ37%、9%およ
び2%であつた。
DL−バリン−2− 13Cを添加して培養した培
養物を過し、菌体をメタノール抽出した。これ
に水を加えて50%メタノール溶液にし、n−ヘキ
サンで抽出した。得られたn−ヘキサン層は芒硝
で脱水後、減圧下で濃縮し、オイル状物質を得
た。このオイル状物質をシリカゲルカラムさらに
ローバーカラム(メルク社製)で精製し、B−41
物質の各成分を単離した。得られた各成分中の
13Cの取り込みを、400メガヘルツの 13C−NMR
及びマス・スペクトルで測定したところ、DL−
バリン−2− 13Cの 13CがB−41D、EおよびG
のC−25位に特異的に取り込まれている事がわか
つた。
実施例 2
実施例1の種培養物をグルコース6%、アスパ
ラギン0.3%、ロイシン0.5%、リン酸第2カリウ
ム0.05%、硫酸マグネシウム0.05%、食塩0.05%、
塩化カルシウム0.02%、硫酸亜鉛0.005%、硫酸
マンガン0.001%、硫酸第1鉄0.002%及び微量の
ビタミン類からなる培地20mlに1mlづつ接種し、
L−バリン、イソ酪酸、2−ケトイソ吉草酸、イ
ソカプロン酸及びイソブタノールを第1表に示す
条件で添加して、28℃で8日間振とう培養した結
果、第1表に示す結果が得られた。
The present invention relates to an industrially advantageous method for producing antibiotics B-41D, E and G useful as anthelmintics and acaricides. B-41D, E, and G are antibiotics obtained by culturing B-41-producing bacteria belonging to the genus Streptomyces, such as the B-41-146 strain, and have the following structural formula, It has been shown in Japanese Unexamined Patent Application Publication No. 2003-12113 that it is effective in exterminating helminths that parasitize animals, especially nematodes, and mites that parasitize animals and plants.
Publication No. 56-32481, Japanese Patent Application No. 55-153141
57-77686) and Japanese Patent Application No. 56-7091 (Japanese Unexamined Patent Publication No. 57-120589). By the way, when B-41-producing bacteria are cultured in the usual manner, B-41A 1 , A 3 , B 2 having a methyl group at the 25th position and B-41 having an ethyl group at the 25th position correspond to the above structural formula. To produce 41A 4 , B 3 , B 2 , etc. at the same time,
The most active B- with isopropyl group at position 25
A method for producing 41D, E, and G with higher yields is desired. The present inventors have discovered that when culturing B-41-producing bacteria, by adding a specific substance to the medium,
-41D, E and G were found to be produced in high yields. The present invention relates to B-41 which belongs to the genus Streptomyces.
When producing B-41D, E and G by culturing production bacteria, from valine, isobutyric acid, isovaleric acid, 2-ketoisovaleric acid, isocaproic acid, salts or esters of these acids, isobutanol and its esters. This is a method for producing B-41D, E, and G, which is characterized by adding one or more selected types to a medium. B-41 producing bacteria, such as Streptomyces B-
Strain 41-146 has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry, as FAIKEN Article No. 1072, and its mycological properties are described in detail in JP-A-50-29472. The bacteria used in the present invention include the above B-41-146 strain, for example, by X-ray irradiation,
Those that have been artificially modified using ultraviolet irradiation, radiation irradiation, or artificial mutating agents and that have the ability to produce B-41D, E, and G are included. In the method of the present invention, the L-form or DL optical isomer of valine added to the medium is used. Among valine, isobutyric acid, isovaleric acid, 2-ketoisovaleric acid, and isocaproic acid, L- or DL valine, isobutyric acid, and 2-ketoisovaleric acid are preferably used. Examples of salts of these acids include sodium salts and potassium salts, and examples of esters include lower alkyl esters such as methyl, ethyl, and n-butyl, or benzyl esters. Isobutanol and its esters can also be used, and esters include those with lower saturated fatty acids such as acetic acid and propionic acid. In an experiment using the above additive 13 C-labeled compound, it was confirmed that an isopropyl group was specifically incorporated into the 25th position of the product. The amount of these additives added to the medium is generally 0.001 to 1 W/V%, preferably 0.005 to 0.01 W/V%.
V% is added. The addition time may be during preparation of the medium or at an appropriate stage during culture. The medium used for culturing the B-41-producing microorganisms may be one that contains nutritional sources that can be used by the microorganisms, and in addition to the above additives, carbon sources include glucose, sucrose, starch, glycerin, and starch syrup. , molasses,
Soybean oil is used, and nitrogen sources include skim milk, soybean flour, wheat germ, meat extract, peptone,
Yeast cells, corn steep liquor, ammonium sulfate, ammonium nitrate, etc. are used. In addition, calcium carbonate, common salt, potassium chloride, and phosphates can be added as necessary. The most suitable culture method is the liquid culture method, especially the deep culture method, similar to the method for producing general antibiotics. Cultivation is carried out under aerobic conditions, and the appropriate temperature for cultivation is 22 to 30°C, but in most cases 28°C.
Culture at around ℃. The liquid quality of the medium is approximately PH5.5-8.0
It is best to have a pH between 6.5 and 7.5, preferably around neutral pH, to obtain better results. Culture is B-
The process is continued until the accumulated concentration of 41D, E, and G reaches the maximum, but the time required for this depends on the culture method, temperature,
Although it varies depending on conditions such as the composition of the medium, it usually takes about 5 to 15 days. B-41 The following method is used to test each component. That is, 3 ml of the culture is placed in a small test tube, 7 ml of acetone is added, shaken, extracted, and centrifuged. TLC 10-20μ of the supernatant obtained here.
The sample was adsorbed onto a predetermined position on a commercial plate (Merck, Kieselgel 60 F 254 ), developed with dioxane:carbon tetrachloride (18:82) for 4 hours, and then exposed to a wavelength of 245 nm using a dual wavelength chromatography scanner. (The blank is
380nm), and the absorption amount is compared with that of the standard substance and calculated. When collecting B-41D, E, and G from cultures, adsorbents such as activated carbon, alumina, and silica gel, synthetic adsorbents such as Diaion HP-10 and HP-20 (manufactured by Mitsubishi Chemical Corporation), Avicel (manufactured by Asahi Kasei Corporation), a fixing agent such as paper, an ion exchange resin, an ion exchange gel filter, etc. can be used, but the collection method shown below is the most effective. The target product is dissolved in methanol water by separating the culture using a supernatant such as diatomaceous earth and extracting the resulting cake with methanol. After adding water to this, extraction is performed with n-hexane, and this is concentrated under reduced pressure to obtain an oily substance containing the target product. This was adsorbed on a column of silica gel (Wako Gel C-200) and eluted with n-hexane:acetone (95:5) to obtain a fraction containing B-41D.
Collect the fraction containing 41E and the fraction containing B-41G. Each fraction was concentrated under reduced pressure and the resulting residue was added to a small amount of n
- When dissolved in hexane:ethyl acetate (20:1) and allowed to stand at room temperature, B-41D, B-41E, and B-41G are obtained in crystalline form, respectively. According to the method of the present invention, the production ratio of B-41D, E, and G components in particular is very high, and the amount produced is also increased, making separation and purification easy, making it an extremely advantageous method for industrial production. The present invention will be specifically described below with reference to Examples. Example 1 Seed medium (sucrose 1%, polypeptone 0.35
%, K 2 HPO 4 0.05%) was dispensed into a 500 ml Erlenmeyer flask, and after sterilization, one loopful of strain B-41-146 was inoculated and cultured at 28° C. for 48 hours to serve as a seed culture. Add 1 ml of this to main medium (4% glucose, 1 ml of soybean flour)
%, skim milk 1%, NaCl 0.3%, corn steep liquor 0.2% and CaCO 3 0.05%) 20ml
Inoculate a 100ml Erlenmeyer flask and incubate at 28°C.
After shaking culture for 3 days, DL-valine-2-
13 C was added at a concentration of 0.01 W/V%, and the cells were cultured for an additional 2 days. At the end of the culture, of the B-41 group antibiotics produced in the culture, B-41D accounted for approximately 65%, E accounted for 18%, and G accounted for 5%. When cultured without additives, the proportions of D, E, and G were 37%, 9%, and 2%, respectively. A culture cultured with the addition of DL-valine- 2-13C was filtered, and the bacterial cells were extracted with methanol. Water was added to this to make a 50% methanol solution, and the mixture was extracted with n-hexane. The obtained n-hexane layer was dehydrated with Glauber's salt and concentrated under reduced pressure to obtain an oily substance. This oily substance was purified using a silica gel column and a Lorber column (manufactured by Merck & Co.), and B-41
Each component of the material was isolated. In each component obtained
13C uptake was performed using 13C -NMR at 400 MHz.
When measured by mass spectrometry, DL−
Valine-2- 13 C of 13 C is B-41D, E and G
It was found that the protein was specifically incorporated into the C-25 position. Example 2 The seed culture of Example 1 was mixed with 6% glucose, 0.3% asparagine, 0.5% leucine, 0.05% dipotassium phosphate, 0.05% magnesium sulfate, 0.05% salt,
Inoculate 1 ml each into 20 ml of a medium consisting of 0.02% calcium chloride, 0.005% zinc sulfate, 0.001% manganese sulfate, 0.002% ferrous sulfate, and trace amounts of vitamins.
L-valine, isobutyric acid, 2-ketoisovaleric acid, isocaproic acid, and isobutanol were added under the conditions shown in Table 1, and cultured with shaking at 28°C for 8 days. As a result, the results shown in Table 1 were obtained. Ta.
【表】
実施例 3
実施例1に示した種培地を調製し、その600ml
を2000mlエルレンマイヤーフラスコに分注し、滅
菌した。これにB−41−146株を1白金耳接種し、
48時間28℃で培養を行ない、この2000mlエルレン
マイヤーフラスコ2本を30ジヤー・フアメンタ
に移植した。ジヤー・フアメンタには、グルコー
ス4%、大豆粉1%、コーンスターチ0.5%、ス
キムミルク1%、コーンスチープ・リカー0.2%、
食塩0.3%及びCaCO30.05%を含有する培地20
を仕込み、PHを7.2〜7.5に調節し、十分に滅菌し
ておいた。培養期間中は、28℃、内圧0.5Kg/cm2
に保持した。3日培養後DL−バリンを0.01%添
加しさらに5日間培養した。B−41群抗生物質総
生産量のうちDは68%(重量比)の割合を占め
た。同条件でDL−バリンを添加せず培養した場
合には、B−41Dの割合は35%にとどまつた。
DL−バリンを添加して得られた培養物20のPH
を硫酸で3とし、セライト1Kgを加えて加圧過
すると約3Kgのケーキが得られた。これを15の
メタノールで抽出し、別し、得られたメタノー
ル溶液15に水10を加え、20のn−ヘキサン
で抽出した。得られたn−ヘキサン層は芒硝で脱
水後、40〜45℃水浴中で減圧下濃縮すると23gの
オイルが得られた。これを約30mlのn−ヘキサン
にとかし、あらかじめ2Kgのシリカゲルをn−ヘ
キサンでつめてあるカラムに吸着せしめ、n−ヘ
キサン:アセトン(95:5)で展開した。その結
果目的物質B−41Dを含有するフラクシヨンを
2.5得た。これらを前述と同様の条件で濃縮す
るとB−41Dの粗結晶が得られた。これをn−ヘ
キサン:酢酸エチル(20:1)に溶解後、室温に
放置し、析出する結晶を取し、B−41Dの精結
晶210mgを得た。[Table] Example 3 Prepare the seed medium shown in Example 1, and add 600 ml of it.
was dispensed into 2000 ml Erlenmeyer flasks and sterilized. One loopful of B-41-146 strain was inoculated into this,
Culture was carried out at 28° C. for 48 hours, and the two 2000 ml Erlenmeyer flasks were transferred to a 30-jar famenta. Jiya Huamenta contains 4% glucose, 1% soy flour, 0.5% corn starch, 1% skim milk, 0.2% corn steep liquor,
Medium containing 0.3% NaCl and 0.05 % CaCO20
was prepared, the pH was adjusted to 7.2 to 7.5, and it was thoroughly sterilized. During the culture period, the temperature was 28℃ and the internal pressure was 0.5Kg/ cm2.
was held at After 3 days of culture, 0.01% DL-valine was added and cultured for an additional 5 days. Of the total production of group B-41 antibiotics, D accounted for 68% (weight ratio). When cultured under the same conditions without adding DL-valine, the proportion of B-41D remained at 35%.
PH of culture 20 obtained with addition of DL-valine
was adjusted to 3 with sulfuric acid, 1 kg of Celite was added, and the mixture was filtered under pressure to obtain a cake weighing approximately 3 kg. This was extracted with 15 parts of methanol and separated, 10 parts of water was added to the obtained methanol solution 15 parts, and extracted with 20 parts of n-hexane. The obtained n-hexane layer was dehydrated with Glauber's salt and concentrated under reduced pressure in a 40-45°C water bath to obtain 23 g of oil. This was dissolved in about 30 ml of n-hexane, adsorbed onto a column packed with 2 kg of silica gel in advance with n-hexane, and developed with n-hexane:acetone (95:5). As a result, a fraction containing the target substance B-41D was obtained.
Got 2.5. When these were concentrated under the same conditions as described above, crude crystals of B-41D were obtained. This was dissolved in n-hexane:ethyl acetate (20:1), left to stand at room temperature, and precipitated crystals were collected to obtain 210 mg of crystals of B-41D.
Claims (1)
41生産菌を培養してB−41D、E及びGを製造す
るに際し、バリン、イソ酪酸、イソ吉草酸、2−
ケトイソ吉草酸、イソカプロン酸、これら酸の塩
またはエステル、イソブタノール及びそのエステ
ルから選ばれた1種または2種以上を培地に添加
することを特徴とするB−41D、E及びGの製造
法。 2 B−41生産菌がストレプミセス属B−41−
146株である特許請求の範囲第1項記載の製造法。 3 B−41Dを製造するための特許請求の範囲第
2項記載の製造法。 4 ストレプトミセス属B−41−146株を、L−
またはDL−バリン、イソ酪酸、2−ケトイソ吉
草酸およびこれらの酸の塩またはエステルから選
ばれた1種または2種以上を添加した培地に培養
してB−41Dを製造する特許請求の範囲第1項記
載の製造法。[Claims] 1. Antibiotic B- belonging to the genus Streptomyces
41 When producing B-41D, E and G by culturing production bacteria, valine, isobutyric acid, isovaleric acid, 2-
A method for producing B-41D, E and G, which comprises adding one or more selected from ketoisovaleric acid, isocaproic acid, salts or esters of these acids, isobutanol and esters thereof to the medium. 2 The B-41 producing bacterium is Strepmyces B-41-
146 strain according to claim 1. 3. The manufacturing method according to claim 2 for manufacturing B-41D. 4 Streptomyces genus B-41-146 strain, L-
or B-41D is produced by culturing in a medium supplemented with one or more selected from DL-valine, isobutyric acid, 2-ketoisovaleric acid, and salts or esters of these acids. The manufacturing method described in item 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17806181A JPS5878594A (en) | 1981-11-06 | 1981-11-06 | Preparation of antibiotic substance b-41d, e, and g |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17806181A JPS5878594A (en) | 1981-11-06 | 1981-11-06 | Preparation of antibiotic substance b-41d, e, and g |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5878594A JPS5878594A (en) | 1983-05-12 |
JPS6366200B2 true JPS6366200B2 (en) | 1988-12-20 |
Family
ID=16041918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP17806181A Granted JPS5878594A (en) | 1981-11-06 | 1981-11-06 | Preparation of antibiotic substance b-41d, e, and g |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5878594A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230047163A (en) | 2020-08-06 | 2023-04-06 | 닛토덴코 가부시키가이샤 | Reinforcing film, optical member and electronic member |
KR20230047162A (en) | 2020-08-06 | 2023-04-06 | 닛토덴코 가부시키가이샤 | Reinforcing film, optical member and electronic member |
KR20230047165A (en) | 2020-08-06 | 2023-04-06 | 닛토덴코 가부시키가이샤 | Reinforcing film, optical member and electronic member |
KR20230047164A (en) | 2020-08-06 | 2023-04-06 | 닛토덴코 가부시키가이샤 | Reinforcing film, optical member and electronic member |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES8800986A1 (en) * | 1985-07-27 | 1987-12-01 | Pfizer | Antiparasitic avermectin and milbemycin derivatives and process for their preparation. |
US5840704A (en) * | 1986-07-16 | 1998-11-24 | Pfizer Inc. | Antiparasitic agents and process for their preparation |
US5234831A (en) * | 1987-01-23 | 1993-08-10 | Pfizer Inc | Cultures for production of B avermectins |
US5238848A (en) * | 1987-01-23 | 1993-08-24 | Pfizer Inc | Cultures for production of avermectins |
US5525506A (en) * | 1987-01-23 | 1996-06-11 | Pfizer Inc. | Process for production of avermectins and cultures therefor |
US5240850A (en) * | 1987-10-23 | 1993-08-31 | Pfizer Inc. | Cultures for production of avermectin aglycones |
-
1981
- 1981-11-06 JP JP17806181A patent/JPS5878594A/en active Granted
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230047163A (en) | 2020-08-06 | 2023-04-06 | 닛토덴코 가부시키가이샤 | Reinforcing film, optical member and electronic member |
KR20230047162A (en) | 2020-08-06 | 2023-04-06 | 닛토덴코 가부시키가이샤 | Reinforcing film, optical member and electronic member |
KR20230047165A (en) | 2020-08-06 | 2023-04-06 | 닛토덴코 가부시키가이샤 | Reinforcing film, optical member and electronic member |
KR20230047164A (en) | 2020-08-06 | 2023-04-06 | 닛토덴코 가부시키가이샤 | Reinforcing film, optical member and electronic member |
Also Published As
Publication number | Publication date |
---|---|
JPS5878594A (en) | 1983-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4576961A (en) | Antibiotic heterocyclic oxygen compounds and use | |
CA1335367C (en) | Ks-506 compounds and process for the production thereof | |
JP2728406B2 (en) | Method for producing anti-substance A / 16686 complex | |
JPS6366200B2 (en) | ||
JPS6316120B2 (en) | ||
CH624956A5 (en) | METHOD FOR REMOVING IMPURITIES FROM CLAVULANIC ACID. | |
US2885433A (en) | O-carbamyl-d-serine | |
EP0395106B1 (en) | Demethylallosamidin and a process for production thereof | |
DE2652677C2 (en) | Antibiotics 890A ↓ 1 ↓ and 890A ↓ 3 ↓, processes for their preparation, and antibacterial agents containing these antibiotics | |
EP0652205A2 (en) | Moenomycin degradation products containing hydroxylated or oxidized lateral lipid chain and moenomycin analogs, process for preparing and their use | |
US4229534A (en) | Acetylthienamycin production | |
DE3003359C2 (en) | ||
DK144658B (en) | PROCEDURE FOR THE PREPARATION OF ANTIBIOTIC C-15003 P-4 | |
US4165379A (en) | N-acetyl thienamycin | |
JPS6024717B2 (en) | antibiotic mycoplanesin | |
US4370266A (en) | Mycoplanecin derivatives and their preparation | |
CA1108078A (en) | Fermentation process | |
EP0055929B1 (en) | Antibiotic c-19393 e5 and production thereof | |
JP2897834B2 (en) | Method for producing avermectins A1a, A2a, B1a and B2a by fermentation and a new strain belonging to Streptomyces avermitilis | |
CH643298A5 (en) | PROCESS FOR THE MANUFACTURE OF NEW ANTIBIOTICS. | |
JP2971204B2 (en) | New substance WK-2955 and method for producing the same | |
US4009077A (en) | Process for the preparation of phenopicolinic acid | |
EP0009363A1 (en) | Method of separating cephalosporins | |
JP2858939B2 (en) | Antibiotics AB3217A, AB3217B and AB3217C and their production | |
JPH0429356B2 (en) |